natgillin/translations-raw huggingface dataset:
Merck Healthcare KGaA, Frankfurter Straße 250 D-64293 Darmstadt Germany 
Merck Healthcare KGaA, Frankfurter Straße 250 D-64293 Darmstadt Nemčija
Driving and using machines Cetrotide is not expected to affect your ability to drive and use machines. 
Vpliv na sposobnost upravljanja vozil in strojev Ne pričakuje se, da bi zdravilo Cetrotide vplivalo na vašo sposobnost vožnje in upravljanja strojev.
• If you are injecting every morning: Start your injections on day 5 or 6 of the treatment cycle. 
• Če zdravilo injicirate vsako jutro: Začnite z injiciranjem na 5. ali 6. dan cikla zdravljenja.
- The OHSS may become severe with clearly enlarged ovaries, decreased urine production, weight gain, difficulty breathing or fluid in your stomach or chest. 
• Sindrom OHSS lahko postane resen z vidno povečanimi jajčniki, zmanjšanim proizvajanjem urina, povečanjem telesne mase, oteženim dihanjem ali tekočino v trebuhu ali prsnem košu.
• Patients with severe renal impairment. 
• Bolnice s hudo ledvično okvaro.
In animals as well as in humans, the antagonistic hormonal effects of cetrorelix were fully reversible after termination of treatment. 
Po končanem zdravljenju so bili, tako pri živalih kot pri človeku, antagonistični hormonski učinki cetroreliksa popolnoma reverzibilni.
The subcutaneous administration of single doses (0.25 mg to 3 mg cetrorelix) and also daily dosing over 14 days show linear kinetics. 
Subkutana uporaba enkratnih odmerkov (0,25 mg do 3 mg cetroreliksa) in tudi dnevno odmerjanje, daljše od 14 dni, kaže linearno kinetiko.
HOW TO MIX AND INJECT CETROTIDE 
KAKO MEŠATI IN INJICIRATI ZDRAVILO CETROTIDE
What Cetrotide is and what it is used for 
Kaj je zdravilo Cetrotide in za kaj ga uporabljamo
Cetrorelix showed no mutagenic or clastogenic potential in gene and chromosome mutation assays. 
Cetroreliks v genskih in kromosomskih testih mutagenosti ni pokazal mutagenega ali klastogenega potenciala.
In females, cetrorelix delays the LH surge and consequently ovulation. 
Pri ženskah cetroreliks odloži porast LH in posledično ovulacijo.
• Please carefully read and follow the instructions at the end of this leaflet called ‘How to mix and inject Cetrotide'. 
• Pozorno preberite in upoštevajte navodila 'Kako mešati in injicirati zdravilo Cetrotide', ki se nahajajo na koncu teh navodil.
Studies in animals have indicated that cetrorelix exerts a dose related influence on fertility, reproductive performance and pregnancy. 
Študije na živalih so pokazale, da je vpliv cetroreliksa na plodnost, sposobnost razmnoževanja in nosečnost odvisen od odmerka.
• Do not shake or you will create bubbles in your medicine. 
• Ne tresite, saj bi s tem povzročili nastanek mehurčkov v zdravilu.
• When the syringe is empty, take out the grey needle slowly at the same angle. 
• Ko je brizga prazna, počasi izvlecite sivo iglo pod istim kotom.
• Clean the skin at your chosen injection site with your second alcohol swab - use a circular motion. 
• Na izbranem mestu injiciranja očistite kožo z drugo alkoholno blazinico - uporabljajte krožne gibe.
The most commonly reported adverse reactions are local injection site reactions such as erythema, swelling and pruritus that are usually transient in nature and mild in intensity. 
Neželeni učinki, o katerih so najpogosteje poročali, so lokalne reakcije na mestu injiciranja, kot so eritem, oteklina in srbenje, ki so običajno prehodne in blage.
What Cetrotide is and what it is used for What you need to know before you use Cetrotide How to use Cetrotide 
Kaj je zdravilo Cetrotide in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Cetrotide Kako uporabljati zdravilo Cetrotide Možni neželeni učinki
Cetrorelix competes with the binding of endogenous LHRH to these receptors. 
Cetroreliks tekmuje z endogenim LHRH za te receptorje.
Piercing your skin 
Prebadanje kože
Re-filling the syringe with the medicine from the vial 
Ponovno polnjenje brizge z zdravilom iz viale
Using this medicine This medicine is only for injection just under the skin of your belly (subcutaneous). 
To zdravilo je namenjeno samo dajanju v obliki injekcije tik pod kožo v trebuh (subkutano).
- Lower abdominal pain together with feeling sick (nausea) or being sick (vomiting) may be the symptoms of OHSS. 
• Bolečina v spodnjem delu trebuha in občutek siljenja na bruhanje (slabost) ali bruhanje so lahko simptomi OHSS.
1 pre-filled syringe contains 1 ml of water for injections. 
1 napolnjena injekcijska brizga vsebuje 1 ml vode za injekcije.
Marketing Authorisation Holder Merck Europe B.V., Gustav Mahlerplein 102, 1082 MA Amsterdam, The Netherlands 
Imetnik dovoljenja za promet z zdravilom Merck Europe B.V., Gustav Mahlerplein 102, 1082 MA Amsterdam, Nizozemska
Manufacturer Merck Healthcare KGaA, Frankfurter Straße 250, D-64293 Darmstadt, Germany 
Izdelovalec Merck Healthcare KGaA, Frankfurter Straße 250, D-64293 Darmstadt, Nemčija
• While carefully holding the syringe and vial, swirl gently to mix the powder and water together. 
• Brizgo in vialo previdno držite ter ju nežno zavrtite, da se voda in prašek zmešata.
Mixing the powder and water to make up your medicine 
Mešanje praška in vode za pripravo zdravila
Inject the contents of one vial (0.25 mg Cetrotide) once each day. 
Injicirajte vsebino ene viale (0,25 mg zdravila Cetrotide), vsak dan enkrat.
• LHRH controls another hormone, called LH (‘luteinising hormone'). 
• LHRH nadzoruje drug hormon, imenovan LH (‘luteinizirajoči hormon').
Experience of using Cetrotide during more than one cycle is small. 
Uporaba zdravila Cetrotide v več kot enem ciklusu Izkušenj z jemanjem zdravila Cetrotide v več kot enem ciklusu je malo.
No formal drug-drug interaction studies have been performed with cetrorelix. 
Formalnih študij medsebojnega delovanja zdravil s cetroreliksom niso izvedli.
• This section tells you how to mix the powder and the sterile water (solvent) together and then how to inject your medicine. 
• V tem poglavju boste našli navodila, kako zmešati prašek in sterilno vodo (vehikel) in kako injicirati zdravilo.
In vitro investigations have shown that interactions are unlikely with medicinal products that are metabolised by cytochrome P450 or glucuronised or conjugated in some other way. 
Raziskave in vitro so pokazale, da so interakcije z zdravili, ki se presnavljajo s citokromom P450, glukuronidirajo ali konjugirajo na kakšen drug način, le malo verjetne.
Treatment with Cetrotide is not advised in women with severe allergic conditions. 
Zdravljenje z zdravilom Cetrotide se odsvetuje ženskam s hudimi alergijskimi stanji.
Pre-filled syringe (Type I glass) with plunger stopper (siliconised bromobutyl rubber) and tip cap (polypropylene and styrene butadiene rubber). 
Napolnjena injekcijska brizga (steklo tipa I) z batnim zamaškom (silikonizirana bromobutilna guma) in pokrovčkom (polipropilen in stiren butadien guma).
It is available in packs of 1 vial and 1 pre-filled syringe or 7 vials and 7 pre-filled syringes (not all pack sizes may be marketed). 
Na voljo je v pakiranju z 1 vialo in 1 napolnjeno injekcijsko brizgo ali s 7 vialami in 7 napolnjenimi injekcijskimi brizgami (na trgu morda ni vseh navedenih pakiranj).
• If any medicine is left in the vial, pull out the yellow needle until the end of the needle is just inside the rubber stopper. 
• Če v viali ostane nekaj zdravila, rumeno iglo izvlecite toliko, da konec igle komaj sega v gumijasti zamašek.
The unopened medicine may be stored in the original package at room temperature (not above 30°C) for up to three months. 
Neodprto zdravilo lahko shranjujete v originalni ovojnini pri sobni temperaturi (do 30 °C) do tri mesece.
Method of administration Cetrotide is for subcutaneous injection into the lower abdominal wall. 
Način uporabe Zdravilo Cetrotide je namenjeno za subkutano injiciranje v spodnji del trebušne stene.
• Put the cap back on the yellow needle. 
• Zaporko namestite nazaj na rumeno iglo.
5 How to store Cetrotide Contents of the pack and other information How to mix and inject Cetrotide 
Shranjevanje zdravila Cetrotide Vsebina pakiranja in dodatne informacije Kako mešati in injicirati zdravilo Cetrotide
If you notice any of the side effects above, stop using Cetrotide and contact your doctor immediately. 
Če opazite katerega koli od zgoraj navedenih neželenih učinkov, prenehajte jemati zdravilo Cetrotide in nemudoma obvestite svojega zdravnika.
Treatment with Cetrotide should commence on day 5 of ovarian stimulation (approximately 96 to 108 hours after start of ovarian stimulation) with urinary or recombinant gonadotropins and is to be continued throughout the gonadotropin treatment period until the evening prior to the day of ovulation induction. 
Zdravljenje z zdravilom Cetrotide moramo začeti na 5. dan ovarijske stimulacije (približno 96 do 108 ur po začetku ovarijske stimulacije) z urinskimi ali rekombinantnimi gonadotropini in ga nadaljujemo ves čas zdravljenja z gonadotropini, vse do večera pred dnevom indukcije ovulacije.
• Wipe the rubber stopper and metal ring with your first alcohol swab. 
• Gumijasti zamašek in kovinski obroček obrišite s prvo alkoholno blazinico.
Powder Mannitol 
Prašek manitol
Treatment with Cetrotide should commence on day 5 or 6 of ovarian stimulation (approximately 96 to 120 hours after start of ovarian stimulation) with urinary or recombinant gonadotropins and is to be continued throughout the gonadotropin treatment period including the day of ovulation induction. 
Zdravljenje z zdravilom Cetrotide moramo začeti na 5. ali 6. dan ovarijske stimulacije (približno 96 do 120 ur po začetku ovarijske stimulacije) z urinskimi ali rekombinantnimi gonadotropini in ga nadaljujemo ves čas zdravljenja z gonadotropini, vključno z dnevom indukcije ovulacije.
• In the solvent: water for injections. 
• V vehiklu: voda za injekcije.
Other medicines and Cetrotide Tell your doctor if you are using, have recently used or might use any other medicines. 
Obvestite zdravnika, če uporabljate, ste pred kratkim uporabljali ali pa boste morda začeli uporabljati katero koli drugo zdravilo.
Then, gently pull back the plunger, in order to draw the medicine from the vial into the syringe. 
Nato bat brizge nežno povlecite nazaj, da povlečete zdravilo iz viale v brizgo.
LHRH binds to membrane receptors on pituitary cells. 
LHRH se veže na membranske receptorje hipofiznih celic.
Inversely, severe OHSS remains uncommon. 
Nasprotno pa se hud OHSS pojavi le občasno.
The reconstituted solution is without particles and clear. 
Rekonstituirana raztopina ne vsebuje delcev in je bistra.
• If you are injecting every evening: Start your injections on day 5 of the treatment cycle. 
• Če zdravilo injicirate zvečer: Začnite z injiciranjem 5. dan cikla zdravljenja.
• Gently pinch up the skin around where you are going to inject and hold this firmly with your other hand. 
• Kožo okoli mesta injiciranja nežno stisnite in jo čvrsto držite z drugo roko.
• Slowly push in the plunger of the syringe to inject the water into the vial. 
• Počasi potiskajte bat brizge, da vodo injicirate v vialo.
• one vial of powder 
• eno vialo praška
In acute toxicity studies in rodents non-specific toxic symptoms were observed after intraperitoneal administration of cetrorelix doses more than 200 times higher than the pharmacologically effective dose after subcutaneous administration. 
V študijah akutne toksičnosti z glodalci so opazili nespecifične toksične znake po intraperitonealni aplikaciji cetroreliksa v odmerkih, ki so bili 200-krat večji od farmakološko učinkovitega odmerka po subkutani uporabi.
No signs of medicinal product-related local irritation or incompatibility were noted in dogs after intravenous, intraarterial and paravenous injection when cetrorelix was administered in doses clearly above the intended clinical use in man. 
Prav tako ni bilo znakov z zdravilom povezanega lokalnega draženja ali inkompatibilnosti pri psih, po intravenski, intraarterijski in paravenski injekciji cetroreliksa v odmerkih, ki so izrazito presegali namen klinične uporabe pri človeku.
Uncommonly, cases of hypersensitivity reactions including pseudo-allergic/anaphylactoid reactions have been reported. 
Poročali so o občasnih primerih preobčutljivostnih reakcij, vključno s psevdoalergijskimi/anafilaktoidnimi reakcijami.
The solution should be used immediately after preparation. 
Raztopino morate uporabiti takoj po pripravi.
CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 0.25 mg 
VSEBINA, IZRAŽENA Z MASO, PROSTORNINO ALI ŠTEVILOM ENOT 0,25 mg
• Push the yellow needle through the centre of the rubber stopper of the vial. 
• Rumeno iglo potisnite skozi sredino gumijastega zamaška viale.
Do not use if the solution contains particles or if the solution is not clear. 
Ne uporabljajte raztopine, če vsebuje delce ali če ni bistra.
Paediatric population There is no relevant use of Cetrotide in the paediatric population. 
Pediatrična populacija Zdravilo Cetrotide ni namenjeno za uporabo pri pediatrični populaciji.
Appearance of the powder: white lyophilisate Appearance of the solvent: clear and colourless solution The pH of the reconstituted solution is 4.0-6.0. 
FARMACEVTSKA OBLIKA prašek in vehikel za raztopino za injiciranje Videz praška: bel liofilizat Videz vehikla: bistra in brezbarvna raztopina pH rekonstituirane raztopine je 4,0 do 6,0.
You will keep using this medicine up until and including the morning that your eggs are collected (ovulation induction). 
Zdravilo boste uporabljali do in vključno z jutrom, ko bodo odvzeta vaša jajčeca (indukcija ovulacije).
The solvent is a clear and colourless solution in a pre-filled syringe. 
Vehikel je bistra in brezbarvna raztopina v napolnjeni injekcijski brizgi.
1 vial and 1 pre-filled syringe or 7 vials and 7 pre-filled syringes. 
1 viala in 1 napolnjena injekcijska brizga ali 7 vial in 7 napolnjenih injekcijskih brizg.
The white powder comes in a glass vial with a rubber stopper. 
Bel prašek je na voljo v stekleni viali z gumijastim zamaškom.
Cetrorelix is a luteinising hormone releasing hormone (LHRH) antagonist. 
Cetroreliks je antagonist luteinizirajoči hormon sproščajočega hormona (LHRH).
UNIQUE IDENTIFIER - 2D BARCODE 2D barcode carrying the unique identifier code 18. 
EDINSTVENA OZNAKA - DVODIMENZIONALNA ČRTNA KODA Vsebuje dvodimenzionalno črtno kodo z edinstveno oznako.
You will keep using this medicine up until and including the evening before your eggs are collected (ovulation induction). 
Zdravilo boste uporabljali do in vključno z večerom pred odvzemom jajčec (indukcija ovulacije).
Cetrotide belongs to a group of medicines called ‘anti-gonadotropin-releasing hormones'. 
Zdravilo Cetrotide spada v skupino zdravil, ki se imenujejo 'antagonisti gonadotropin sproščajočega hormona'.
During or following ovarian stimulation an ovarian hyperstimulation syndrome can occur. 
Sindrom ovarijske hiperstimulacije (OHSS, Ovarian Hyperstimulation Syndrome) Med ovarijsko stimulacijo ali po njej se lahko pojavi sindrom ovarijske hiperstimulacije.
• Slowly push the grey needle completely into your skin at an angle of about 45 to 
• Sivo iglo počasi v celoti potisnite v kožo pod kotom okoli 45 do 90 stopinj - nato kožo spustite.
• Leave the syringe in the rubber stopper. 
• Brizgo pustite v gumijastem zamašku.
• Choose an injection site on your belly. 
• Izberite mesto za injiciranje na trebuhu, najbolje okoli popka.
• take out the grey needle slowly at the same angle 
• Počasi izvlecite sivo iglo pod istim kotom.
Do not use this medicine after the expiry date which is stated on the carton, vial and pre-filled syringe after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na kartonski škatli, viali in napolnjeni injekcijski brizgi poleg oznake EXP. Rok uporabnosti zdravila se izteče na zadnji dan navedenega meseca.
• Hold the syringe with the grey needle pointing upwards and check for any air bubbles. 
• Brizgo s sivo iglo držite obrnjeno navzgor in preverite ali so v njej zračni mehurčki.
Preparing the injection site and injecting your medicine 
Priprava mesta injiciranja in injiciranje zdravila
The powder vial contains 0.25 mg cetrorelix and the pre-filled syringe contains 1 ml solvent. 
Viala praška vsebuje 0,25 mg cetroreliksa, napolnjena injekcijska brizga pa vsebuje 1 ml vehikla.
• use your second alcohol swab to gently apply pressure where you have just pierced your skin 
• Z drugo alkoholno blazinico nežno pritisnite na mesto, kjer ste prebodli kožo.
This medicine must be at room temperature prior to injection. 
Zdravilo mora pred injiciranjem imeti sobno temperaturo.
Ovarian Hyperstimulation Syndrome (OHSS) This may occur due to the other medicines that you are using to stimulate your ovaries. 
Do OHSS lahko pride zaradi uporabe drugih zdravil, ki jih jemljete za stimuliranje jajčnikov.
Cetrotide blocks a natural hormone in your body called LHRH (‘luteinising hormone releasing hormone'). 
Zdravilo Cetrotide blokira naravni hormon v vašem telesu, imenovan LHRH ('gonadotropin sproščajoči hormon').
• one pre-filled syringe with sterile water (solvent) 
• eno napolnjeno injekcijsko brizgo s sterilno vodo (vehikel)
• Mild and short-lasting skin irritation may occur at the injection site like redness, itching or swelling. 
• blago in kratkotrajno draženje kože se lahko pojavi na mestu injiciranja, kot je pordela koža,
Cetrotide should only be reconstituted with the solvent provided, using a gentle, swirling motion. 
Zdravilo Cetrotide smete rekonstituirati samo s priloženim vehiklom, z rahlim vrtenjem.
Uncommon: Systemic allergic/pseudo-allergic reactions including life-threatening anaphylaxis. 
Sistemske alergijske/psevdoalergijske reakcije, vključno z življenjsko nevarno anafilaktično reakcijo.
• one needle with a yellow mark - for injecting the sterile water into the vial and drawing the made-up medicine out from the vial 
• eno iglo z rumeno oznako - za injiciranje sterilne vode v vialo in za odvzem pripravljenega zdravila iz viale
1 injection needle (20 gauge) 
1 injekcijsko iglo (20 G)
7 injection needles (20 gauge) 7 hypodermic injection needles (27 gauge) 14 alcohol swabs. 
7 injekcijskih igel (20 G) 7 subkutanih injekcijskih igel (27 G) 14 alkoholnih blazinic
How to use Cetrotide 
Kako uporabljati zdravilo Cetrotide
Mild to moderate OHSS (WHO grade I or II) can occur which is an intrinsic risk of the stimulation procedure (see section 4.4). 
stopnje po SZO), ki je intrinzično tveganje postopka stimulacije (glejte poglavje 4.4).
Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction. 
Predklinični podatki na osnovi običajnih študij farmakološke varnosti, toksičnosti pri ponavljajočih odmerkih, genotoksičnosti, kancerogenega potenciala in vpliva na sposobnost razmnoževanja ne kažejo posebnega tveganja za človeka.
If you notice any of the side effects above, contact your doctor immediately. 
Če opazite katerega koli od zgoraj navedenih neželenih učinkov, o tem nemudoma obvestite svojega zdravnika.
When it is mixed, it will look clear and have no particles in it. 
Ko sta voda in prašek zmešana, bo vsebina bistra in ne bo vsebovala delcev.
Remove the cap from the vial 
Z viale odstranite zaporko
This medicinal product must be allowed to reach room temperature prior to injection. 
Zdravilo mora pred injiciranjem doseči sobno temperaturo.
Do not use the prepared solution in the vial if it is not clear and colourless or if it has particles in it. Do not throw any medicines via wastewater or household waste. 
Ne uporabljajte pripravljene raztopine v viali, če ni več bistra in brezbarvna ali če vsebuje delce.
Cetrorelix has not been studied in patients with renal impairment and caution is therefore warranted. 
Cetroreliksa niso preučili pri bolnicah z ledvično okvaro, zato je pri njih potrebna previdnost.
Unscrew the yellow needle from the syringe and lay down the syringe. 
Rumeno iglo odvijte z brizge in brizgo odložite.
• Use your second alcohol swab to gently apply pressure where you have just injected. 
• Z drugo alkoholno blazinico nežno pritisnite na mesto, kjer ste injicirali zdravilo.
Cetrotide contains a medicine called ‘cetrorelix'. 
Cetrotide je zdravilo, ki vsebuje učinkovino cetroreliks.
Remove the cap from the needle. 
Z igle odstranite zaporko.
• You start by using another medicine on day 1 of your treatment cycle. 
• Na začetku, prvi dan cikla zdravljenja, vzamete drugo zdravilo.
How Cetrotide works 
Kako deluje zdravilo Cetrotide
• Unwrap the needle with the yellow mark on it. 
• Odvijte iglo, ki ima rumeno oznako.
• one needle with a grey mark - for injecting the medicine into your belly 
• eno iglo s sivo oznako - za injiciranje zdravila v trebuh
Cetrotide is used together with other medicines that stimulate your ovaries to develop more eggs ready to be released. 
Sindrom hiperstimulacije jajčnikov (OHSS, Ovarian Hyperstimulation Syndrome) Zdravilo Cetrotide se uporablja skupaj z drugimi zdravili, ki stimulirajo jajčnike, da proizvedejo več jajčec za sprostitev.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON OF 1 VIAL AND 1 PRE-FILLED SYRINGE CARTON OF 7 VIALS AND 7 PRE-FILLED SYRINGES 
KARTONSKA ŠKATLA Z 1 VIALO IN 1 NAPOLNJENO INJEKCIJSKO BRIZGO KARTONSKA ŠKATLA S 7 VIALAMI IN 7 NAPOLNJENIMI INJEKCIJSKIMI BRIZGAMI
1 injection needle (20 gauge) 1 hypodermic injection needle (27 gauge) 2 alcohol swabs. 
1 injekcijska igla (20 G) 1 subkutana injekcijska igla (27 G) 2 alkoholni blazinici
Allergies Tell your doctor before using Cetrotide if you have an active allergy or have had allergies in the past. 
Preden začnete uporabljati zdravilo Cetrotide, obvestite zdravnika, če imate oz. ste v preteklosti imeli alergije.
Hepatic impairment Cetrorelix has not been studied in patients with hepatic impairment and caution is therefore warranted. 
Jetrna okvara Cetroreliksa niso preučili pri bolnicah z jetrno okvaro, zato je pri njih potrebna previdnost.
Tell your doctor before using Cetrotide if you have a kidney disease. 
Pred uporabo zdravila Cetrotide obvestite zdravnika, če imate ledvično bolezen.
Vigorous shaking with bubble formation should be avoided. 
Izogibati se morate močnemu stresanju zdravila s tvorbo mehurčkov.
Mild to moderate OHSS (WHO grade I or II) have been commonly reported and should be considered as an intrinsic risk of the stimulation procedure. 
stopnje po SZO), ki ga je treba upoštevati kot intrinzično tveganje postopka stimulacije.
Tell your doctor before using Cetrotide if you have a liver disease. 
Pred uporabo zdravila Cetrotide obvestite zdravnika, če imate jetrno bolezen.
What Cetrotide is used for 
Za kaj se uporablja zdravilo Cetrotide
• Ask your pharmacist how to safely dispose of used needles, vial and syringe. 
• O varnem odstranjevanju uporabljenih igel, vial in brizg se posvetujte s farmacevtom.
Each vial contains 0.25 mg cetrorelix (as acetate). 
Vsaka viala vsebuje 0,25 mg cetroreliksa (v obliki acetata).
Cetrorelix dose-dependently inhibits the secretion of LH and FSH from the pituitary gland. 
Cetroreliks zavira izločanje LH in FSH iz hipofize v odvisnosti od odmerka.
No target organ toxicity could be observed from acute, subacute and chronic toxicity studies in rats and dogs following subcutaneous administration of cetrorelix. 
V študijah akutne, subakutne in kronične toksičnosti pri podganah in psih po subkutani aplikaciji cetroreliksa niso opazili toksičnosti za ciljne organe.
Common (may affect up to 1 in 10 women): 
Pogosti (pojavijo se lahko pri največ 1 od 10 žensk):
1 hypodermic injection needle (27 gauge) 
1 subkutano injekcijsko iglo (27 G)
Bad effects are not expected if you accidentally inject more of this medicine than you should. 
Če ste uporabili večji odmerek zdravila Cetrotide, kot bi smeli Ni verjetno, da bi prišlo do neželenih učinkov, če bi si pomotoma injicirali več zdravila Cetrotide, kot bi smeli.
• Remove the cap from the pre-filled syringe and screw the yellow needle onto it. 
• Z napolnjene brizge odstranite zaporko in nanjo privijte rumeno iglo.
After reconstitution with the solvent provided, each mL of the solution contains 0.25 mg cetrorelix. 
Po rekonstituciji s priloženim vehiklom vsebuje en ml raztopine 0,25 mg cetroreliksa.
1 powder vial with 0.25 mg cetrorelix. 
1 viala praška z 0,25 mg cetroreliksa.